State Street Corp Exelixis, Inc. Transaction History
State Street Corp
- $2.41 Trillion
- Q3 2024
A detailed history of State Street Corp transactions in Exelixis, Inc. stock. As of the latest transaction made, State Street Corp holds 11,443,668 shares of EXEL stock, worth $387 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,443,668
Previous 12,601,656
9.19%
Holding current value
$387 Million
Previous $283 Million
4.87%
% of portfolio
0.01%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding EXEL
# of Institutions
502Shares Held
243MCall Options Held
2.54MPut Options Held
2.29M-
Black Rock Inc. New York, NY33.5MShares$1.13 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.3MShares$991 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA25.4MShares$859 Million3.31% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.4MShares$519 Million0.63% of portfolio
-
Lsv Asset Management Chicago, IL8.1MShares$274 Million0.45% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $10.9B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...